Strand, V., de Vlam, K., Covarrubias-Cobos, J. A., Mease, P. J., Gladman, D. D., Chen, L., . . . Hsu, M. (2019). Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond. RMD Open.
Citação norma ChicagoStrand, Vibeke, et al. "Effect of Tofacitinib On Patient-reported Outcomes in Patients With Active Psoriatic Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors in the Phase III, Randomised Controlled Trial: OPAL Beyond." RMD Open 2019.
Citação norma MLAStrand, Vibeke, et al. "Effect of Tofacitinib On Patient-reported Outcomes in Patients With Active Psoriatic Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors in the Phase III, Randomised Controlled Trial: OPAL Beyond." RMD Open 2019.